Lysine

Lysine

SCHEMBL8585752

C=CC=O.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.74
ARG2 P78540 4/20 0.47
ARG1 P05089 3/20 0.47
RNPEP Q9H4A4 1/20 0.46
NOS2 P35228 5/20 0.42
NOS1 P29475 3/20 0.42
CYP1A2 P05177 3/20 0.42
NOS3 P29474 2/20 0.42
TSHR P16473 2/20 0.42
CYP3A4 P08684 1/20 0.42
CPB2 Q96IY4 2/20 0.42
GLA P06280 1/20 0.42
NFKB1 P19838 1/20 0.42
APEX1 P27695 1/20 0.42
CYP2C19 P33261 1/20 0.42
BLM P54132 1/20 0.41
GRM8 O00222 1/20 0.41
GRM6 O15303 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL8817755 1.00 GSR (0.74) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL445453 0.90 GSR (0.83) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL17102268 0.90 GSR (0.83) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL5359221 0.89 GSR (0.80) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL28520628 0.87 GSR (0.77) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL19100135 0.87 GSR (0.77) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL19100137 0.87 GSR (0.77) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL2324976 0.86 GSR (0.83) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL22534312 0.86 GSR (0.83) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL8562830 0.86 GSR (0.83) GSRARG2ARG1RNPEPNOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997013148-A9 METHOD FOR MEASURING FREE RADICAL CYTOTOXIC DEGRADATION 1997-11-06 WO claimed
WO-1997013148-A1 METHOD FOR MEASURING FREE RADICAL CYTOTOXIC DEGRADATION STANINGER HILDEGARDE L A (US) 1997-04-10 WO claimed
WO-2012125582-A1 BIOMARKER FOR CORONARY ARTERY DISEASE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2012-09-20 WO disclosed
EP-0759750-A4 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO HOWARD K (US) 1998-05-27 EP disclosed
EP-0759750-A1 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO, Howard, K. (US) 1997-03-05 EP disclosed
WO-1995031194-A1 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO HOWARD K (US) 1995-11-23 WO disclosed